Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The trust factor

Bruce A Chabner

    The Oncologist
    |April 19, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cerebral Folate Deficiency, Autism, and the Role of Leucovorin.

    The New England journal of medicine·2026
    Same author

    Reinventing chemotherapy.

    The oncologist·2025
    Same author

    Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study.

    The oncologist·2023
    Same author

    Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.

    The oncologist·2022
    Same author

    Supreme Court and the Practice of Oncology.

    The oncologist·2022
    Same author

    Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants.

    JCO oncology practice·2022
    Same journal

    Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

    The oncologist·2026
    Same journal

    Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

    The oncologist·2026
    Same journal

    Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

    The oncologist·2026
    Same journal

    Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

    The oncologist·2026
    Same journal

    Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

    The oncologist·2026
    Same journal

    Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

    The oncologist·2026
    See all related articles